117 completed, 17 unknown, 9 terminated, 8 withdrawn. 161 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 161 | Completed 117, Unknown 17, Terminated 9, Withdrawn 8, Recruiting 5, Not yet recruiting 4, Active not recruiting 1 |
Follow Lens Diseases: new trials by email Literature Review of Lens Diseases trials Research Report on Lens Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Evaluation of Visual Performance, Spectacle Independence, and Patient Satisfaction With TECNIS PureSee Mini-Monovision and TECNIS PureSee-TECNIS Odyssey Mix-Match TECNIS PureSee IOL (Model DEN00V/DET150), TECNIS Odyssey IOL (Model DRN00V/DRT150) - Presbyopia Correction, Presbyopia | Phase 4 | Not yet recruiting | Dr. Daniel H. Chang, MD | 68 | 2026-10-01 | 2026-10-06 |
| A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the TECNIS PureSee™ Extended Depth of Focus Intraocular Lens PureSee IOL - Cataract | Phase 4 | Not yet recruiting | Vance Thompson Vision | 50 | 2026-09-01 | 2026-08-27 |
| Toric Performance And Constant Evaluation Monofocal toric IOL - Cataract | Phase 4 | Recruiting | Carl Zeiss Meditec AG | 130 | 2026-07-13 | 2026-07-22 |
| A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects Clareon TruPlus, Clareon monofocal - Cataract | Phase 4 | Recruiting | Berkeley Eye Center | 180 | 2026-06-12 | 2026-07-21 |
| Rebamipide Versus Diquafosol for Perioperative Dry Eye in Cataract Surgery Rebamipide 2% ophthalmic solution, Diquafosol 3% ophthalmic solution - Dry Eye Disease (DED), Cataract | Phase 4 | Not yet recruiting | Samsung Medical Center | 60 | 2026-03-01 | 2026-02-09 |
| Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery Aflibercept (Eylea) - Diabetic Retinopathy (DR), Diabetic Macular Edema (DME) | Phase 4 | Not yet recruiting | Ahmad Zeeshan Jamil | 166 | 2026-01-01 | 2025-12-24 |
| Odyssey Evaluation in Post LASIK Patients Odyssey intraocular lens - Cataract | Phase 4 | Active not recruiting | Center For Sight | 30 | 2025-08-18 | 2026-10-26 |
| Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery Rebamipide 2% ophthalmic solution, Diquafosol 3% ophthalmic solution, Cyclosporine 0.05% ophthalmic solution - Dry Eye Disease (DED), Cataract | Phase 4 | Completed | Samsung Medical Center | 56 | 2025-08-01 | 2026-10-27 |
| Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops eye drops - Dry Eye, Cataract | Phase 4 | Recruiting | Ace Cells Lab Limited | 300 | 2025-04-22 | 2025-09-25 |
| A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects Clareon PanOptix, Clareon PanOptix PRO, Mix-and-Match PanOptix/Vivity - Cataract | Phase 4 | Recruiting | Berkeley Eye Center | 320 | 2025-03-17 | 2026-09-30 |
| Evaluation of a Monofocal Intraocular Lens CT LUCIA 621P - Cataract | Phase 4 | Completed | Carl Zeiss Meditec AG | 44 | 2024-06-06 | 2026-07-22 |
| Symfony vs Vivity in Dim Light Symfony IOL, Vivity IOL - Cataract | Phase 4 | Completed | Carolina Eyecare Physicians, LLC | 64 | 2023-12-01 | 2025-02-14 |
| The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers Omega-3, Trehalose, Zocular Eyelid System Treatment - Dry Eye, Dry Eye Syndromes | Phase 4 | Unknown | Uptown Eye Specialists | 68 | 2023-09-01 | 2023-08-14 |
| Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery Bromfenac, Moxifloxacin 0.5% ophthalmic solution, Dexamethasone phosphate 0.1% - Cataract, Cystoid Macular Edema After Phacoemulsification | Phase 4 | Completed | Inas Abd | 87 | 2023-05-01 | 2025-05-06 |
| The Evaluation of Balanced Salt Solution During Cataract Surgery BSS Plus, BSS - Fuchs Dystrophy, Cataract | Phase 4 | Completed | Adam Fedyk, MD, FACS | 26 | 2023-04-17 | 2025-07-03 |
| A Study for Post op Inflammation After Cataract Surgery Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% - Cataract | Phase 4 | Unknown | Wyse Eyecare | 40 | 2023-01-30 | 2023-04-26 |
| Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL. Dextenza 0.4Mg Ophthalmic Insert - Cataract | Phase 4 | Completed | Iworks Laser and Vision Center | 80 | 2022-06-15 | 2023-08-23 |
| Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population Dropless Regimen, Standard Regimen - Cataract, Surgery | Phase 4 | Recruiting | University of California, San Francisco | 70 | 2022-05-31 | 2026-10-27 |
| Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract Dexamethasone, Prednisolone Acetate Ophthalmic - Cataract | Phase 4 | Terminated | EyePoint Pharmaceuticals, Inc. | 17 | 2022-01-04 | 2026-10-05 |
| The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1 Dexamethasone 0.4 MG [Dextenza] - Cataract | Phase 4 | Completed | Grene Vision Group | 23 | 2021-12-13 | 2023-07-06 |
Showing 20 of 161. Sign in to see all of them.
Cataract (159) · Dry Eye Syndromes (9) · Glaucoma (5) · Inflammation (5) · Macular Edema (5) · Aphakia (4) · Astigmatism (4) · Pseudophakia (4) · Glaucoma, Open-Angle (3) · Capsule Opacification (2) · Exfoliation Syndrome (2) · Mydriasis (2) · Presbyopia (2) · Vision Disorders (2)
Eye Diseases (160) · Pathological Conditions, Signs and Symptoms (13) · Lacrimal Apparatus Diseases (9) · Retinal Diseases (8) · Retinal Degeneration (7) · Ocular Hypertension (6) · Pathologic Processes (6) · Refractive Errors (6) · Signs and Symptoms (6) · Macular Degeneration (5) · Endocrine System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Corneal Diseases (2) · Diabetes Mellitus (2)
prednisolone acetate (14) · Calcium Dobesilate (12) · Ophthalmic Solutions (10) · bromfenac (9) · Ketorolac (8) · Moxifloxacin (8) · Phacoemulsification (8) · Cataract Extraction (7) · Dexamethasone (7) · nepafenac (7) · Lenses, Intraocular (5) · Epinephrine (3) · Ketorolac Tromethamine (3) · Levofloxacin (3) · Methylprednisolone (3)
Alcon Research (23) · Innovative Medical (13) · Bausch & Lomb Incorporated (8) · Carl Zeiss Meditec AG (4) · Aurolab (3) · Carolina Eyecare Physicians, LLC (3) · Frank A. Bucci, Jr., M.D. (3) · Hospital Hietzing (3) · Hospital Oftalmologico de Brasilia (3) · Indiana University (3) · Technolas Perfect Vision GmbH (3) · Berkeley Eye Center (2) · Bp Consulting, Inc (2) · Bucci Laser Vision Institute (2) · Federal University of São Paulo (2)
United States (81) · Germany (10) · Brazil (8) · India (8) · Austria (7) · Czechia (4) · China (3) · South Korea (3) · Taiwan (3) · United Kingdom (3) · Canada (2) · Egypt (2) · Singapore (2) · Spain (2) · Argentina (1)
Louis B Cantor, MD (3) · Eckart Bertelmann, MD, PhD (2) · Frank A Bucci, Jr., MD (2) · Frank A. Bucci, Jr., MD (2) · Gabriele Brenger (2) · Haripriya Aravind, MBBS, MS (2) · Kerry D Solomon, MD (2) · Matthias G Wirtitsch, MD (2) · Nadja Karnik, MD (2) · Patrick F Tzelikis, MD, PhD (2) · Phillip J Buckhurst, PhD (2) · Abayomi Ogundele, PharmD (1) · Abhay R Vasavada, MS,FRCS (1)
PMID 12231329, PMID 15030845, PMID 15232477, PMID 15313288, PMID 16286622, PMID 16863978, PMID 17276271, PMID 18165083, PMID 18211932, PMID 18291345, PMID 18599019, PMID 20216291, PMID 21187730, PMID 21704965, PMID 21940140, PMID 24339307, PMID 25385061, PMID 25880685, PMID 29669780, PMID 32818353, PMID 33086290, PMID 34383010, PMID 35067660, PMID 39127813, PMID 40146119, PMID 40977319
R01AG015812 (1)